Сomparative effectiveness of calcium antagonists of prolonged action in patients with stable angina pectoris

2023

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.30629/0023-2149-2022-100-11-12-551-554
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The article is devoted to investigation the comparative efficacy of therapy with drugs of calcium antagonists with prolong action — dilren and altiasem PP in old patients, suffering from ischemic heart disease, stable stenocardia 2–3 functional class. There were established more efficacy of therapy with dilren then altiasem PP in the relation to clinical symptoms, hemodynamical parameters and their circadian chronostructure. These data manifested by more essential antianginal, antiischemic and vasodilated effects of dilren then of altiasem PP. There were more essential the increase of tolerance to physical loading, promotion of pumping myocardial function under the influence of dilren and tendency to normalization in circadian organization of hemodynamic parameters.